What is the diagnosis for a patient with a history of hepatocellular carcinoma (HCC) treated with durvalumab (durvalumab) and lenvatinib (lenvatinib) presenting with painless gross hematuria and anemia, leukopenia, and thrombocytopenia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Differential Diagnosis for Painless Frank Hematuria and Low Hemoglobin, WBC, and Platelets in a Patient with History of HCC Treated with Durvalumab and Lenvatinib

  • Single Most Likely Diagnosis
    • Metastatic disease to the urinary tract: Given the patient's history of hepatocellular carcinoma (HCC) and treatment with durvalumab (an immune checkpoint inhibitor) and lenvatinib (a tyrosine kinase inhibitor), the most likely cause of painless frank hematuria could be metastasis to the urinary tract. The low hemoglobin could be due to chronic blood loss, while the low WBC and platelets might be side effects of the treatments or indicative of bone marrow involvement.
  • Other Likely Diagnoses
    • Hemorrhagic cystitis: This condition, characterized by bleeding from the bladder mucosa, can be a side effect of certain medications, radiation, or infections. Given the patient's treatment regimen, this could be a plausible cause for hematuria.
    • Urinary tract infection (UTI) or sepsis: Although less likely given the description of "painless," a UTI could lead to hematuria and affect blood cell counts, especially if it progresses to sepsis.
    • Thrombocytopenia or bone marrow suppression: Lenvatinib can cause thrombocytopenia, and both drugs can lead to bone marrow suppression, which might explain the low platelet count and potentially the low WBC count.
  • Do Not Miss Diagnoses
    • Bleeding disorder: The combination of hematuria and low platelets could suggest a bleeding disorder, either as a side effect of medication or an underlying condition that needs urgent attention.
    • Sepsis: Although mentioned earlier, sepsis is a critical condition that can present with nonspecific symptoms, including changes in blood cell counts, and is always a "do not miss" diagnosis due to its high mortality rate if not promptly treated.
  • Rare Diagnoses
    • Paraneoplastic syndrome: Certain cancers can cause paraneoplastic syndromes that lead to a variety of symptoms, including hematologic abnormalities. While rare, this could be a consideration in a patient with a known malignancy.
    • Drug-induced hemolytic anemia: Although rare, some drugs can induce hemolytic anemia, which could explain the low hemoglobin and potentially other cytopenias if there's an immune-mediated response affecting other cell lines.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.